Serum cytokines levels in Graves' disease
- PMID: 11500727
Serum cytokines levels in Graves' disease
Abstract
Objective: The aim of the study was to look at the serum cytokines profile in newly diagnosed thyrotoxic patients with Graves' disease and to compare their cytokine levels with those of normal control subjects. Furthermore, the levels of T4, being an indicator of the severity of thyrotoxicosis, were also correlated with the Th1/Th2 and proinflammatory cytokines in Graves' disease patients.
Methods: Serum IFN-gamma (Th1), IL-10 (Th2), inflammatory cytokines including IL-6, TNF-alpha, sCD23 and sIL-2R cytokine levels were measured in 28 patients with Graves' thyrotoxicosis and in 30 normal controls.
Results: In Graves' disease patients, the levels of IFN-gamma (mean 142.1 +/- 29.53 units/ml), IL-10 (mean 583.8 +/- 253.3 pg/ml) and IL-4 (mean 132.4 +/- 44.52 pg/ml) were significantly higher than their corresponding levels in controls: IFN-gamma (mean 31.6 +/- 2.08 units/ml, P<0.001), IL-10 (mean 69.8 +/- 31.72 pg/ml, P<0.001) and IL-4 (mean 46.44 +/- 11.53 pg/ml). There was a marked increase in proinflammatory cytokines in Graves' disease patients: levels of IL-6 (481.5 +/- 192.3 pg/ml) and TNF-alpha (30.69 +/- 16.7 pg/ml) were significantly higher than those of normal controls for IL-6 (63.81 +/- 21.72 pg/ml, P<0.001) and TNF-alpha (8.81 +/- 1.72 pg/ml, P<0.001). Similarly the levels of sCD23 (mean 164 +/- 67.03 ng/ml) and sIL-2R (mean 2131 +/- 461.1 units/ml) were significantly higher in GD patients than in the control group (mean 31.24 +/- 11.53 ng/ml, P<0.001) and (mean 345.53 +/- 121.75 units/ml, P< 0.001) for sCD23 and sIL-2R. Furthermore, in thyrotoxic Graves' disease patients, we detected a positive correlation between free T4 and sIL-2R levels (r2 = 0.81, P<0.00), but no significant correlation was found between T4 and the other measured cytokines.
Conclusion: The elevated serum cytokines of Graves' thyrotoxic patients reflect the activation and interplay of mixed Th1 and Th2 cells which may be consistent with long standing inflammatory and destructive processes of thyroid gland. The clinical severity of hyperthyroidism in Graves' patients only correlated with sIL-2R.
Similar articles
-
[A study of cytokine expression in peripheral blood of patients with Graves' ophthalmopathy].Zhonghua Yan Ke Za Zhi. 2002 Mar;38(3):165-7. Zhonghua Yan Ke Za Zhi. 2002. PMID: 11955323 Chinese.
-
Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).Neuroimmunomodulation. 2004;11(4):209-13. doi: 10.1159/000078438. Neuroimmunomodulation. 2004. PMID: 15249726
-
Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.Horm Metab Res. 2001 Dec;33(12):739-43. doi: 10.1055/s-2001-19135. Horm Metab Res. 2001. PMID: 11753760
-
Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.Cytokine. 2006 Aug;35(3-4):109-14. doi: 10.1016/j.cyto.2006.08.002. Epub 2006 Sep 27. Cytokine. 2006. PMID: 17008110 Review.
-
Three-year-old boy presenting in thyrotoxicosis.J Am Osteopath Assoc. 1998 Feb;98(2):112-4. J Am Osteopath Assoc. 1998. PMID: 9509838 Review.
Cited by
-
Modulating gut microbiota in a mouse model of Graves' orbitopathy and its impact on induced disease.Microbiome. 2021 Feb 16;9(1):45. doi: 10.1186/s40168-020-00952-4. Microbiome. 2021. PMID: 33593429 Free PMC article.
-
Dendritic cells infected with adenovirus expressing the thyrotrophin receptor induce Graves' hyperthyroidism in BALB/c mice.Clin Exp Immunol. 2003 Feb;131(2):234-40. doi: 10.1046/j.1365-2249.2003.02080.x. Clin Exp Immunol. 2003. PMID: 12562382 Free PMC article.
-
An association of interleukin-10 gene polymorphisms with Graves' disease in two Chinese populations.Endocrine. 2011 Aug;40(1):90-4. doi: 10.1007/s12020-011-9444-7. Epub 2011 Mar 18. Endocrine. 2011. PMID: 21424183
-
The effects of royal jelly on autoimmunity in Graves' disease.Endocrine. 2006 Oct;30(2):175-83. doi: 10.1385/ENDO:30:2:175. Endocrine. 2006. PMID: 17322576
-
Increased expression of IL-37 in patients with Graves' disease and its contribution to suppression of proinflammatory cytokines production in peripheral blood mononuclear cells.PLoS One. 2014 Sep 16;9(9):e107183. doi: 10.1371/journal.pone.0107183. eCollection 2014. PLoS One. 2014. PMID: 25226272 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources